These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7603364)

  • 1. Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues.
    Machida H; Nishitani M; Watanabe Y; Yoshimura Y; Kano F; Sakata S
    Microbiol Immunol; 1995; 39(3):201-6. PubMed ID: 7603364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA synthesis in varicella-zoster virus-infected cells by BV-araU.
    Machida H; Watanabe Y
    Microbiol Immunol; 1991; 35(2):139-45. PubMed ID: 1653394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure.
    Machida H; Nishitani M; Ashida N
    Microbiol Immunol; 1994; 38(2):109-15. PubMed ID: 8041297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
    Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
    Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral potencies of BV-araU and related nucleoside analogues against varicella-zoster virus in different cell lines.
    Machida H; Ijichi K; Ohta A; Honda M; Niimura M
    Microbiol Immunol; 1990; 34(11):959-65. PubMed ID: 1965323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
    Kawai H; Yoshida I; Suzutani T
    Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
    Balzarini J; McGuigan C
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
    Andrei G; Sienaert R; McGuigan C; De Clercq E; Balzarini J; Snoeck R
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1081-6. PubMed ID: 15728906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
    Andrei G; Snoeck R; Reymen D; Liesnard C; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):318-29. PubMed ID: 7649195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
    Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
    J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
    Koyano S; Suzutani T; Yoshida I; Azuma M
    Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of [3H]1-beta-D-arabinofuranosyl-5-[(E)-2-bromovinyl]uracil in herpes simplex virus type 1-infected cells.
    Ashida N; Sakata S; Machida H
    Microbiol Immunol; 1997; 41(12):957-64. PubMed ID: 9492181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Sakuma T
    Antimicrob Agents Chemother; 1984 Jun; 25(6):742-6. PubMed ID: 6331298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus.
    Shigeta S; Yokota T; Iwabuchi T; Baba M; Konno K; Ogata M; De Clercq E
    J Infect Dis; 1983 Mar; 147(3):576-84. PubMed ID: 6300257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus.
    Shiraki K; Ochiai H; Namazue J; Okuno T; Ogino S; Hayashi K; Yamanishi K; Takahashi M
    Antiviral Res; 1992 Jun; 18(2):209-14. PubMed ID: 1329651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
    Standring-Cox R; Bacon TH; Howard BA
    J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of protein kinase (ORF47)-deficient varicella-zoster virus strains to anti-herpesvirus nucleosides.
    Suzutani T; Ogasawara M; Shibaki T; Azuma M
    Antiviral Res; 2000 Jan; 45(1):79-82. PubMed ID: 10774592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication.
    Lin JC; Reefschläger J; Herrmann G; Pagano JS
    Antiviral Res; 1992 Jan; 17(1):43-52. PubMed ID: 1310582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.